Insider Trading activities of Synergetics Usa Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Synergetics Usa Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Synergetics Usa Inc since year 2005. Table 2 shows the detailed insider transactions of Synergetics Usa Inc since 2005. The reporting company's ticker symbol is SURG. The reporting company's CIK number is 836429.
The total value of stock buying since 2005 is $542,330.
The total value of stock sales since 2005 is $4,940,585.
The total value of stock option exercises since 2005 is $457,350.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Synergetics Usa Inc (SURG).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2015-09 0 $0 0 $0 20,000 $100,000
2014-12 0 $0 18,000 $76,707 0 $0
2014-10 1,000 $3,361 0 $0 0 $0
2014-06 0 $0 0 $0 20,000 $22,700
2014-03 4,257 $12,978 0 $0 0 $0
2014-01 0 $0 2,290 $7,957 10,000 $9,000
2013-12 1,000 $3,550 0 $0 20,000 $26,900
2013-10 0 $0 154,000 $701,673 0 $0
2013-03 9,300 $30,928 0 $0 0 $0
2012-12 0 $0 0 $0 51,310 $55,627
2012-06 6,800 $27,325 0 $0 0 $0
2012-04 0 $0 0 $0 10,000 $27,500
2012-03 13,000 $74,155 0 $0 0 $0
2012-02 0 $0 3,940 $27,580 0 $0
2012-01 0 $0 20,000 $149,260 0 $0
2011-12 0 $0 76,000 $535,600 0 $0
2011-10 2,500 $15,729 44,600 $267,600 0 $0
2011-04 2,000 $10,720 47,800 $286,800 0 $0
2011-03 0 $0 199,000 $1,101,521 0 $0
2011-02 0 $0 108,600 $582,639 0 $0
2011-01 2,500 $11,675 231,000 $1,118,249 38,417 $45,524
2010-10 7,000 $20,450 0 $0 60,000 $170,099
2008-12 10,000 $8,980 0 $0 0 $0
2008-10 40,350 $62,829 0 $0 0 $0
2008-01 10,000 $24,800 0 $0 0 $0
2007-12 20,000 $46,520 0 $0 0 $0
2007-07 10,000 $35,250 0 $0 0 $0
2007-05 0 $0 250 $1,187 0 $0
2007-04 0 $0 17,281 $83,812 0 $0
2007-03 5,000 $17,150 0 $0 0 $0
2006-12 15,000 $70,298 0 $0 0 $0
2006-04 7,000 $46,960 0 $0 0 $0
2005-12 5,200 $18,672 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Synergetics Usa Inc insiders (SURG)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2015-09-18 Cardinale Lawrence C Option Ex 10,000 5.00 50,000
2015-09-18 Hinshaw Juanita H Option Ex 10,000 5.00 50,000
2014-12-31 Fanning Michael (VP of Domestic Sales) Sale 5,000 4.32 21,600
2014-12-22 Fanning Michael (VP of Domestic Sales) Sale 13,000 4.24 55,107
2014-10-20 Thomas David Graeme Buy 1,000 3.36 3,361
2014-06-18 Guarch Guy R Option Ex 10,000 1.37 13,700
2014-06-16 Dick Robert H Option Ex 10,000 .90 9,000
2014-03-26 Hable David M (President and CEO) Buy 3,257 3.04 9,904
2014-03-21 Thomas David Graeme Buy 1,000 3.07 3,074
2014-01-13 Guarch Guy R Option Ex 10,000 .90 9,000
2014-01-03 Fanning Michael (VP of Domestic Sales) Sale 2,290 3.48 7,957
2013-12-20 Cardinale Lawrence C Option Ex 10,000 .90 9,000
2013-12-16 Dick Robert H Option Ex 10,000 1.79 17,900
2013-12-12 Thomas David Graeme Buy 1,000 3.55 3,550
2013-10-16 Malis Jerry L (EVP & Chief Scientific Officer) Sale 10,000 4.57 45,710
2013-10-15 Malis Jerry L (EVP & Chief Scientific Officer) Sale 20,000 4.55 91,039
2013-10-14 Malis Jerry L (EVP & Chief Scientific Officer) Sale 20,000 4.56 91,120
2013-10-11 Fanning Michael (VP of Domestic Sales) Sale 4,000 4.67 18,692
2013-10-10 Malis Jerry L (EVP & Chief Scientific Officer) Sale 28,873 4.60 132,902
2013-10-09 Malis Jerry L (EVP & Chief Scientific Officer) Sale 6,532 4.59 29,975
2013-10-08 Malis Jerry L (EVP & Chief Scientific Officer) Sale 15,200 4.58 69,540
2013-10-07 Malis Jerry L (EVP & Chief Scientific Officer) Sale 25,000 4.54 113,625
2013-10-04 Malis Jerry L (EVP & Chief Scientific Officer) Sale 24,395 4.47 109,070
2013-03-20 Fanning Michael (VP of Domestic Sales) Buy 2,000 3.43 6,860
2013-03-19 Fanning Michael (VP of Domestic Sales) Buy 2,800 3.26 9,128
2013-03-18 Fanning Michael (VP of Domestic Sales) Buy 4,500 3.32 14,940
2012-12-27 Boone Pamela G (EVP & Chief Financial Officer) Option Ex 41,310 1.09 45,027
2012-12-13 Dick Robert H Option Ex 10,000 1.06 10,600
2012-06-14 Hable David M (President and CEO) Buy 4,000 4.03 16,111
2012-06-14 Boone Pamela G (EVP & Chief Financial Officer) Buy 2,800 4.00 11,214
2012-04-10 Dick Robert H Option Ex 10,000 2.75 27,500
2012-03-15 Hable David M (President and CEO) Buy 4,000 5.86 23,440
2012-03-15 Gampp Kurt W Jr (EVP & Chief Operating Officer) Buy 9,000 5.64 50,715
2012-02-17 Malis Jerry L (EVP & Chief Scientific Officer) Sale 1,500 7.00 10,500
2012-02-09 Malis Jerry L (EVP & Chief Scientific Officer) Sale 2,000 7.00 14,000
2012-02-06 Malis Jerry L (EVP & Chief Scientific Officer) Sale 40 7.00 280
2012-02-03 Malis Jerry L (EVP & Chief Scientific Officer) Sale 400 7.00 2,800
2012-01-03 Malis Jerry L (EVP & Chief Scientific Officer) Sale 20,000 7.46 149,260
2011-12-30 Malis Jerry L (EVP & Chief Scientific Officer) Sale 10,000 7.36 73,600
2011-12-16 Gampp Kurt W Jr (EVP & Chief Operating Officer) Sale 66,000 7.00 462,000
2011-10-20 Boone Pamela G (EVP & Chief Financial Officer) Buy 1,000 6.40 6,399
2011-10-18 Williams Patricia S Buy 1,500 6.22 9,330
2011-10-11 Gampp Kurt W Jr (EVP & Chief Operating Officer) Sale 44,600 6.00 267,600
2011-04-07 Boone Pamela G (EVP & Chief Financial Officer) Buy 2,000 5.36 10,720
2011-04-04 Gampp Kurt W Jr (EVP & Chief Operating Officer) Sale 47,800 6.00 286,800
2011-03-22 Gampp Kurt W Jr (EVP & Chief Operating Officer) Sale 7,600 6.00 45,600
2011-03-21 Gampp Kurt W Jr (EVP & Chief Operating Officer) Sale 57,000 5.56 317,205
2011-03-11 Gampp Kurt W Jr (EVP & Chief Operating Officer) Sale 43,000 5.51 236,930
2011-03-11 Malis Jerry L (Chief Scientific Officer) Sale 91,400 5.49 501,786
2011-02-09 Malis Jerry L (Chief Scientific Officer) Sale 108,600 5.36 582,639
2011-01-26 Malis Jerry L (Chief Scientific Officer) Sale 150,000 4.91 736,800
2011-01-24 Malis Jerry L (Chief Scientific Officer) Sale 29,289 4.67 136,779
2011-01-21 Malis Jerry L (Chief Scientific Officer) Sale 493 4.65 2,292
2011-01-20 Malis Jerry L (Chief Scientific Officer) Sale 33,918 4.66 158,023
2011-01-19 Malis Jerry L (Chief Scientific Officer) Sale 300 4.65 1,395
2011-01-06 Hable David M (President and CEO) Sale 17,000 4.88 82,960
2011-01-06 Hable David M (President and CEO) Option Ex 38,417 1.18 45,524
2011-01-04 Boone Pamela G (EVP & Chief Financial Officer) Buy 2,500 4.67 11,675
2010-10-19 Guarch Guy R (Director) Buy 2,000 2.95 5,900
2010-10-19 Malis Jerry L (Chief Scientific Officer) Option Ex 50,000 2.80 140,000
2010-10-18 Boone Pamela G (EVP & Chief Financial Officer) Buy 5,000 2.91 14,550
2010-10-15 Dick Robert H (Director) Option Ex 10,000 3.01 30,099
2008-12-16 Boone Pamela G (EVP & Chief Financial Officer) Buy 10,000 .90 8,980
2008-10-17 Gampp Kurt W Jr (EVP & Chief Operating Officer) Buy 12,900 1.54 19,866
2008-10-17 Guarch Guy R (Director) Buy 4,000 1.60 6,400
2008-10-17 Boone Pamela G (EVP & Chief Financial Officer) Buy 15,000 1.56 23,430
2008-01-10 Cardinale Lawrence C (Director) Buy 10,000 2.48 24,800
2007-12-26 Hinshaw Juanita H (Director) Buy 10,000 2.33 23,260
2007-12-26 Boone Pamela G (EVP & Chief Financial Officer) Buy 10,000 2.33 23,260
2007-07-06 Boone Pamela G (EVP & Chief Financial Officer) Buy 10,000 3.52 35,250
2007-05-15 Malis Jerry L (Chief Scientific Officer) Sale 250 4.75 1,187
2007-04-20 Malis Jerry L (Chief Scientific Officer) Sale 200 4.78 957
2007-04-19 Malis Jerry L (Chief Scientific Officer) Sale 2,081 4.76 9,895
2007-04-18 Malis Jerry L (Chief Scientific Officer) Sale 15,000 4.86 72,960
2007-03-22 Gampp Kurt W Jr (EVP & Chief Operating Officer) Buy 5,000 3.43 17,150
2006-12-13 Boone Pamela G (EVP & Chief Financial Officer) Buy 10,000 4.62 46,249
2006-04-12 Boone Pamela G (Chief Financial Officer) Buy 5,000 6.78 33,900
2006-04-11 Guarch Guy R (Director) Buy 2,000 6.53 13,060
2005-12-16 Boone Pamela G (Chief Financial Officer) Buy 5,000 3.59 17,952

Insider trading activities including stock purchases, stock sales, and option exercises of SURG listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Synergetics Usa Inc (symbol SURG, CIK number 836429) see the Securities and Exchange Commission (SEC) website.